Moreover, we observed that in AT-1 cells, the inhibition of SYK by entospletinib generally downregulates the mTOR pathway (Figure S3), as already described in follicular lymphoma [8] and B-ALL [9] cells. Here, SYK is linked to precursor B-cell acute lymphoblastic leukemia.